Editas Medicine Announces Second Quarter 2018 Results and Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- Mahindra & Mahindra Ltd (MM:IN) (MAHMF) PT Raised to INR320 at HSBC
- HSBC Downgrades Shriram Finance Ltd (SHFL:IN) to Hold
- Lockheed Martin to acquire Ultra Maritime for $3.45 billion
- Broadcom, Apple extend chip supply deal through 2031
- Strategy reports $8.32B bitcoin loss and sells BTC to fund dividends
Editas Medicine (EDIT) Misses Q2 EPS by 15c
August 6, 2018 4:36 PM EDTEditas Medicine (NASDAQ: EDIT) reported Q2 EPS of ($0.82), $0.15 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $7.4 million versus the consensus estimate of $6.73 million.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
... More